Semaglutide injections are FDA-approved GLP-1 agonist medications used to treat obesity and aid in dramatic weight loss. Semaglutide are both once-weekly injections that require no change in diet or lifestyle to produce weight loss results of greater than 50 lb in as little as 6 months. When used along with an individualized low-calorie, low-fat diet and exercise program to help with weight loss, overweight adults who may also have high blood pressure, diabetes, or high cholesterol see significant progress across all health markers. Semaglutide injections are a class of medications called glucagon-like-peptide-1 (GLP-1) agonists, although Tirzepatide has enhanced effects as a glucose-dependent insulinotropic polypeptide (GIP) agonist that produce more drastic weight loss results.
Semaglutide therapy is a relatively new form of treatment for type 2 diabetes. Semaglutide is a glucagon-like peptide 1 receptor agonist (GLP-1 RA) that helps to regulate blood glucose levels. Semaglutide works by stimulating the pancreas to produce insulin when blood sugar levels are too high, and inhibiting the release of glucose from the liver when blood sugar is too low. Semaglutide also slows down digestion, helping people with type 2 diabetes absorb food more slowly and keep their blood sugar under control. Semaglutide therapy may be used alone or in combination with other medications and lifestyle modifications such as diet and exercise.
Semaglutide therapy can help improve glycemic control in people with type 2 diabetes, reduce hemoglobin A1c levels, improve beta-cell function and decrease body weight compared to placebo injections. Semaglutide is administered via subcutaneous injection once weekly at a dose of up to 0.9 milligrams per day. Semaglutide has been associated with some adverse effects including nausea, vomiting, constipation, diarrhea and headache, but these are typically mild and transient in nature. Semaglutide also carries a risk of hypoglycemia (low blood sugar), so close monitoring of blood glucose levels is necessary for people taking this medication.
Overall, semaglutide therapy can be an effective treatment option for people with type 2 diabetes who have not achieved adequate glycemic control with existing medications or lifestyle modifications alone. Semaglutide may provide better glycemic control than other GLP-1 RA therapies due to its greater potency and longer half-life in the body. Close monitoring of blood glucose levels is necessary while taking semaglutide due to the risk of hypoglycemia so patients should consult their healthcare provider before starting semaglutide therapy to ensure it is an appropriate treatment option for them.
If you’re ineligible to receive therapy or medications after consultation with Valhalla Vitality provider – you will be fully refunded!